Canada’s Stem Cell Corporation: Aggregate Concerns and the Question of Public Trust

Herder, Matthew; Brian, Jennifer Dyck

doi:10.1007/s10551-006-9294-z

Cited by 15 publications

(7 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 48 Scientists in life sciences feel less and less committed to studying major societal problems if there is a financial incentive to focus on a different research agenda. 49 Another factor to take into account is the confidence in the government as a regulator. A strong association has been found between exposure to corruption in the public sector and a lower likelihood of trust in the private sector.…”

Section: Resultsmentioning

confidence: 99%

Perception of genetically engineered crops in Paraguay

et al. 2021

View full text Add to dashboard Cite

Paraguay is integrated into the world mainly through its agricultural activity. The population’s perception of genetically engineered crops is relevant to design communication strategies that convey the advantages and limitations of the various technologies used in the country. We aimed to know the perception of the population of four Departments of the country where such crops are grown through a survey, which revealed a low level of knowledge about genetically engineered crops in general, and specifically about the effects of genetically engineered crops on production, nutrition, and the environment. Respondents expressed a willingness to receive information on genetically engineered crops, in particular from the National Government and the Health Sector .

show abstract

Section: Resultsmentioning

confidence: 99%

Perception of genetically engineered crops in Paraguay

et al. 2021

View full text Add to dashboard Cite

show abstract

“…This is especially salient in Canada, where economic interests in stem cell research need to be seen within a specific context of collaboration and partial commercialization, controlled by the national Stem Cell Network, Health Canada and -a very recent phenomenon -also by government priorities. Within the last years, there can be observed an increasing demand to commercialize scientific research by the Canadian government, as well as in other domains, such as prisons, the military and in nuclear energy (see Herder and Brian, 2007;Ogbogu, 2008). However, although geographically neighbouring the United States, the politics surrounding stem cell research in Canada are much less economically oriented and less privatized.…”

Section: 'Multiverse' and Bio-technologiesmentioning

confidence: 99%

How to fix a broken heart: Cardiac disease and the ‘multiverse’ of stem cell research in Canada

et al. 2016

View full text Add to dashboard Cite

This article focuses on Canadian stem cell researchers working on therapeutic applications of autologous stem cells for heart disease. Building on the concept of 'multiverse' -coined by William James and then further developed by Ernst Bloch -we are interested in the simultaneity of the certain and uncertain, sometimes contradictory arguments articulated by these scientists. In the first part of the article we illustrate some of the factors that provide certainty for researchers and clinicians. The second part analyzes the ways in which uncertain elements become integrated into a discourse of certainty. What we would like to show, using the concept of multiverse, is that a relatively new bio-technology such as stem cell treatments generally relies on both certain and uncertain reasoning. However, uncertainty has to give way to a platform of partial certainty, if crucial action is to be taken on issues as diverse as treatments and grant applications. The principle mechanisms we found that can make this kind of transformation possible target future developments (what we call 'if only arguments'), including past encouraging results in need of further research. The online version of this article is available Open AccessYou have to have a good cell to repair the heart.(Researcher B)Stem cell treatments, in many cases, are 'technologies of hope' for patients suffering from a severely disabling, sometimes mortal, health condition (see Brown, 2003; also Leibing and

show abstract

“…A portion of this research budget directly funds hES cell research and is also used to leverage additional research funds. Sixth, through its partnerships with industry and specific initiatives like the creation of Aggregate Therapeutics Inc., the SCN's full embrace of commercialization is in keeping with the federal government's core science and technology policy objectives (Herder and Dyck Brian 2008;Government of Canada 2007).…”

Section: Future Policy Design Consultationsmentioning

confidence: 99%

Policy Design for Human Embryo Research in Canada: An Analysis (Part 2 of 2)

Βaylis

Herder

2009

Bioethical Inquiry

Self Cite

View full text Add to dashboard Cite

This article is the second in a two-part review of policy design for human embryo research in Canada. In the first article in 6(1) of the JBI, we explain how this area of research is circumscribed by law promulgated by the federal Parliament and by guidelines adopted by the Tri-Agencies, and we provide a chronological description of relevant policy initiatives and outcomes related to these two policy instruments, with particular attention to the repeated efforts at public consultation. This second article analyses the history of policy design for human embryo research in Canada, applying a typology of modes of public consultation developed by Eric Montpetit to better understand the various episodes of policy design and their corresponding outcomes. On this basis, we suggest that the degree to which the views of Canadian residents and citizens on human embryo research have been solicited as part of the policymaking process has diminished significantly over time. We also suggest that this diminished participation is likely to continue given the presence of powerful interest groups and policy communities "speaking for" Canadians. This raises interesting questions about the legitimacy of future policy initiatives for human embryo research in Canada.

show abstract

Canada’s Stem Cell Corporation: Aggregate Concerns and the Question of Public Trust

Abstract: biotechnology, Canada, commercialization, governance, intellectual property, patent, public trust, stem cell,

Cited by 15 publications

References 37 publications

Perception of genetically engineered crops in Paraguay

Perception of genetically engineered crops in Paraguay

How to fix a broken heart: Cardiac disease and the ‘multiverse’ of stem cell research in Canada

Policy Design for Human Embryo Research in Canada: An Analysis (Part 2 of 2)

Contact Info

Product

Resources

About